Related Experiment Videos
[pS2 protein and breast cancer]
Minerva Ginecologica
|December 1, 1995
Summary
The pS2 protein, elevated in estrogen receptor-positive breast cancers, indicates hormone dependence and better patient survival. Its presence correlates with improved prognosis in breast cancer patients.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- pS2 is a small protein (7000 daltons) predominantly found in human breast cancer.
- Estrogen stimulation induces pS2 protein expression.
- pS2 is also present in normal stomach mucosa, but its function there is unknown.
Purpose of the Study:
- To investigate the role of pS2 protein as a marker in breast cancer.
- To evaluate the association between pS2 expression and patient prognosis.
Main Methods:
- The study likely involved analyzing pS2 protein expression in breast cancer tissues.
- Correlation analysis was performed between pS2 positivity, estrogen receptor status, and survival data.
Main Results:
- pS2 protein expression is prevalent in estrogen receptor-positive breast cancers.
- pS2 expression is associated with longer overall survival and disease-free survival.
- 96% of cases with pS2 positivity also showed positivity for estrogen receptors.
Conclusions:
- pS2 protein serves as a reliable marker for hormone-dependent breast tumors.
- pS2 expression is a significant indicator of a favorable prognosis in breast cancer patients.